Patent classifications
C07C203/02
PROCESS FOR THE PREPARATION OF A-METHYL-[4-(NITRO)-2-(TRIFLUOROMETHYL) -BENZYL NITRATE
The present invention relates to a process for the preparation of α-methyl-[4-(nitro)-2-(trifluoromethyl)]-benzyl nitrate and to the α-methyl-[4-(nitro)-2-(trifluoromethyl)]-benzyl nitrate.
PROCESS FOR THE PREPARATION OF A-METHYL-[4-(NITRO)-2-(TRIFLUOROMETHYL) -BENZYL NITRATE
The present invention relates to a process for the preparation of α-methyl-[4-(nitro)-2-(trifluoromethyl)]-benzyl nitrate and to the α-methyl-[4-(nitro)-2-(trifluoromethyl)]-benzyl nitrate.
PROCESS FOR THE PREPARATION OF OMEGA-ALKANEDIOL MONONITRATE
The invention relates to a safe and efficient process for the solvent removal and recovery by distillation in a process for the preparation of ω-nitrooxy-C3-10alkane-1-ols. The process is safer to operators and allows to obtain advantageous yields on industrial scale.
PROCESS FOR THE PREPARATION OF ALPHA,OMEGA-ALKANEDIOL MONONITRATE
The invention relates to a safe and efficient process for the hydrolysis of α,ω-C.sub.3-10alkanediol mononitrate monoacylates. The process is safer to operators and allows to obtain advantageous yields on industrial scale.
PROCESS FOR THE PREPARATION OF ALPHA,OMEGA-ALKANEDIOL MONONITRATE
The invention relates to a safe and efficient process for the hydrolysis of α,ω-C.sub.3-10alkanediol mononitrate monoacylates. The process is safer to operators and allows to obtain advantageous yields on industrial scale.
PROCESS FOR THE ACYLATION OF AN ALPHA, OMEGA-ALKANDIOL
The invention relates to a safe and efficient process for the for the acylation of an α,ω-alkanediol, which can be used in the manufacture of ω-nitrooxy-C.sub.3-10alkane-1-ols. The process is safer to operators and allows to obtain advantageous yields on industrial scale.
PROCESS FOR NITRATE ESTER FORMATION OF AN ALPHA,OMEGA-ALKANEDIOL MONOACYLATE
The invention relates to a safe and efficient process for the nitrate ester formation of an α,ω-C.sub.3-10alkanediol monoacylate. The process is safer to operators and allows to obtain advantageous yields on industrial scale.
Process for the preparation of a nitric oxide donating prostaglandin analogue
The present invention relates to a process for preparing the hexanoic acid, 6-(nitrooxy)-, (1S,2E)-3-[(1R,2R,3S,5R)-2-[(2Z)-7-(ethylamino)-7-oxo-2-hepten-1-yl]-3,5-dihydroxycyclopentyl]-1-(2-phenylethyl)-2-propen-1-yl ester of formula (I). ##STR00001## In accordance with the present invention, the compound (I) can be efficiently prepared with high purity by coupling bimatoprost in a boronate protected form with 6-(nitrooxy)hexanoyl chloride and removing the boronate protecting group. The 6-(nitrooxy)hexanoyl chloride intermediate is prepared by ring-opening reaction of 2-caprolactone and subsequent nitration of the 6-hydroxyhexanoic acid potassium salt with a mixture of HNO.sub.3 and H.sub.2SO.sub.4 in dichloromethane.
Process for the preparation of a nitric oxide donating prostaglandin analogue
The present invention relates to a process for preparing the hexanoic acid, 6-(nitrooxy)-, (1S,2E)-3-[(1R,2R,3S,5R)-2-[(2Z)-7-(ethylamino)-7-oxo-2-hepten-1-yl]-3,5-dihydroxycyclopentyl]-1-(2-phenylethyl)-2-propen-1-yl ester of formula (I). ##STR00001## In accordance with the present invention, the compound (I) can be efficiently prepared with high purity by coupling bimatoprost in a boronate protected form with 6-(nitrooxy)hexanoyl chloride and removing the boronate protecting group. The 6-(nitrooxy)hexanoyl chloride intermediate is prepared by ring-opening reaction of 2-caprolactone and subsequent nitration of the 6-hydroxyhexanoic acid potassium salt with a mixture of HNO.sub.3 and H.sub.2SO.sub.4 in dichloromethane.
PROCESS FOR THE PREPARATION OF A NITRIC OXIDE DONATING PROSTAGLANDIN ANALOGUE
The present invention relates to a process for preparing the hexanoic acid, 6-(nitrooxy)-, (1S,2E)-3-[(1R,2R,3S,5R)-2-[(2Z)-7-(ethylamino)-7-oxo-2-hepten-1-yl]-3,5-dihydroxycyclopentyl]-1-(2-phenylethyl)-2-propen-1-yl ester of formula (I).
##STR00001##
In accordance with the present invention, the compound (I) can be efficiently prepared with high purity by coupling bimatoprost in a boronate protected form with 6-(nitrooxy)hexanoyl chloride and removing the boronate protecting group.
The 6-(nitrooxy)hexanoyl chloride intermediate is prepared by ring-opening reaction of 2-caprolactone and subsequent nitration of the 6-hydroxyhexanoic acid potassium salt with a mixture of HNO.sub.3 and H.sub.2SO.sub.4 in dichloromethane.